Tema ETFs
VRTX icon

Tema ETFs’s Vertex Pharmaceuticals VRTX Stock Holding History

Tema ETFs’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.39M Buy
10,306
+1,246
+14% +$638K 0.2% 106
2026
Q2 		$4.5M Sell
9,060
-580
-6% -$257K 0.15% 119
2026
Q1 		$4.3M Buy
9,640
+28
+0.3% +$13.1K 0.29% 89
2025
Q4 		$4.36M Sell
9,612
-39
-0.4% -$16.8K 0.34% 87
2025
Q3 		$3.78M Buy
9,651
+1,583
+20% +$662K 0.31% 96
2025
Q2 		$3.59M Sell
8,068
-380
-4% -$175K 0.95% 36
2025
Q1 		$4.1M Sell
8,448
-2,533
-23% -$1.18M 1.22% 20
2024
Q4 		$4.42M Buy
+10,981
New +$5.09M 1.84% 18

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Tema ETFs's VRTX Position: Q3 2026 in Review

Tema ETFs increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q3 2026, buying an estimated $638K and bringing the position to 10,306 shares worth $5.39M. The position accounts for 0.2% of the portfolio, ranked #106.

Tema ETFs first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 291 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Tema ETFs held 10,306 shares of Vertex Pharmaceuticals worth $5.39M as of Q3 2026.
  • Tema ETFs bought 1,246 Vertex Pharmaceuticals shares in Q3 2026, an estimated $638K.
  • Vertex Pharmaceuticals made up 0.2% of Tema ETFs's portfolio in Q3 2026, its #106 holding.
  • Tema ETFs first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 291 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.